IRIDEX Corp. (IRIX)
0.6432
+0.01
(+1.77%)
USD |
NASDAQ |
Oct 02, 16:00
0.6404
0.00 (0.00%)
After-Hours: 20:00
IRIDEX EPS Diluted (Quarterly) : -0.0727 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0727 |
| March 31, 2026 | -0.0303 |
| December 31, 2025 | -0.0107 |
| September 30, 2025 | -0.0925 |
| June 30, 2025 | -0.0592 |
| March 31, 2025 | -0.1008 |
| December 31, 2024 | -0.0501 |
| September 30, 2024 | -0.1166 |
| June 30, 2024 | -0.1645 |
| March 31, 2024 | -0.2131 |
| December 31, 2023 | -0.1822 |
| September 30, 2023 | -0.1081 |
| June 30, 2023 | -0.1725 |
| March 31, 2023 | -0.1306 |
| December 31, 2022 | -0.0718 |
| September 30, 2022 | -0.1105 |
| June 30, 2022 | -0.141 |
| March 31, 2022 | -0.1506 |
| December 31, 2021 | -0.154 |
| September 30, 2021 | -0.1368 |
| June 30, 2021 | 0.0854 |
| March 31, 2021 | -0.1401 |
| December 31, 2020 | -0.0129 |
| September 30, 2020 | -0.1237 |
| June 30, 2020 | -0.2016 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1198 |
| December 31, 2019 | -0.1133 |
| September 30, 2019 | -0.1296 |
| June 30, 2019 | -0.1772 |
| March 31, 2019 | -0.2236 |
| December 31, 2018 | -0.21 |
| September 30, 2018 | -0.2578 |
| June 30, 2018 | -0.28 |
| March 31, 2018 | -0.31 |
| December 31, 2017 | -0.44 |
| September 30, 2017 | -0.27 |
| June 30, 2017 | -0.24 |
| March 31, 2017 | -0.16 |
| December 31, 2016 | -1.04 |
| September 30, 2016 | -0.07 |
| June 30, 2016 | -0.03 |
| March 31, 2016 | 0.01 |
| December 31, 2015 | 0.04 |
| September 30, 2015 | 0.04 |
| June 30, 2015 | -0.07 |
| March 31, 2015 | 0.02 |
| December 31, 2014 | 0.86 |
| September 30, 2014 | 0.05 |
| June 30, 2014 | 0.03 |
| March 31, 2014 | 0.05 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 4.267 |
| Neogen Corp. | -0.0519 |
| QuidelOrtho Corp. | -1.360 |
| Aspira Women's Health, Inc. | -0.0547 |
| Biomerica, Inc. | -0.3729 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.266M |
| Revenue (Quarterly) | 12.57M |
| Total Expenses (Quarterly) | 13.83M |
| Enterprise Value | 16.56M |
| Gross Profit Margin (Quarterly) | 33.56% |
| Profit Margin (Quarterly) | -10.07% |
| Earnings Yield | -32.06% |
| Normalized Earnings Yield | -32.04 |